Opioid use increases risk of serious infections

February 12, 2018, Vanderbilt University Medical Center
Credit: CC0 Public Domain

Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don't use opioids.

The Vanderbilt University Medical Center study, released today by the Annals of Internal Medicine, found that people who use opioids have a 1.62 times higher risk of invasive pneumococcal diseases.

Invasive pneumococcal diseases are serious infections caused by the Streptococcus pneumoniae bacteria, with mortality ranging from 5 percent to 20 percent. These invasive diseases include a range of illnesses such as meningitis, bacteremia and invasive pneumonia.

"The association between use and the risk of invasive pneumococcal diseases was strongest for opioids used at high doses, those classified as high potency and long-acting, which would be the extended release or controlled release formulations," said lead author Andrew Wiese, PhD, MPH, postdoctoral research fellow in the Department of Health Policy at Vanderbilt University School of Medicine.

"We also found that opioids previously described as immunosuppressive in prior experimental studies conducted in animals, had the strongest association with invasive pneumococcal diseases in humans," he said.

Wiese and colleagues, studied Tennessee Medicaid Data to measure daily prescription opioid exposure for each study individual and combined that information with Active Bacterial Core (ABC) surveillance system data, which is a VUMC laboratory and population-based surveillance system conducted in partnership with the Tennessee Department of Health and the CDC Centers for Disease Control and Prevention to monitor invasive infectious diseases in Tennessee.

"A unique feature of the study is the use of laboratory-confirmed infections as study outcomes. The sources of data allowed us to reconstruct and compare the history of opioid exposures in those subjects with and without invasive pneumococcal diseases," said Carlos G. Grijalva, MD, MPH associate professor of Health Policy, and senior author of the study.

The increase in opioid use in the U.S. over the past several years has led to an increased interest towards well-known and also previously under- recognized adverse effects associated with opioid use.

"Previous studies conducted in animal models had demonstrated that certain opioids can cause immunosuppression and render experimental animals susceptible to infections. However, the clinical implications of those observations in humans were unclear" said Grijalva.

In an accompanying editorial, Sascha Dublin, MD, and Michael von Korff, ScD, from the Kaiser Permanente Washington Health Research Institute indicate that this research provides, "...cautionary evidence of a higher risk with prescription opioid use, suggesting the need for prudent steps to protect patients..." They further emphasize the need for judicious prescribing of opioids and conclude that "opioid prescribing should be consistently cautious and closely monitored among all patients, especially those at increased risk for infections, who may be particularly susceptible to harm."

"The findings from our study are clinically relevant. Providers should consider these results when making pain management decisions," added Wiese.

Explore further: Geography matters: Prescribing patterns for opioids in dermatology

Related Stories

Geography matters: Prescribing patterns for opioids in dermatology

February 7, 2018
A new study suggests that opioid prescribing is not widespread among dermatologists, but opportunities exist in concentrated areas to reduce their use. The study appears online Feb. 7 in JAMA Dermatology.

Prescribing of opioids adds to patient satisfaction with care

January 24, 2018
(HealthDay)—Patients with musculoskeletal conditions who are using prescribed opioids are more likely to be highly satisfied with their care, according to a study published in the January/February issue of the Annals of ...

Longer duration of post-op opioid use associated with misuse

January 19, 2018
(HealthDay)—Each refill and week of opioid prescription following surgery is associated with an increasing risk of opioid misuse among opioid naive patients, according to a study published online Jan. 17 in The BMJ.

Gabapentin co-use may increase risk of fatal opioid overdose

October 3, 2017
Co-prescription of the anticonvulsant gabapentin is associated with an increased risk of opioid-related death in people who are prescribed opioid painkillers, according to a new study published in PLOS Medicine.

Opioids tied to higher risk of infections in rheumatoid arthritis

February 15, 2016
(HealthDay)—The use of opioid analgesics may increase the risk of serious infection in patients with rheumatoid arthritis (RA), according to research published in the February issue of Arthritis & Rheumatology.

Long-term opioid use does not increase risk of Alzheimer 's disease

October 24, 2017
Opioid use is not associated with an increased risk of Alzheimer's disease, shows a recent study from the University of Eastern Finland. Researchers did not find any risk neither for long-term use nor for higher cumulative ...

Recommended for you

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

Do price spikes on some generic drugs indicate problems in the market?

October 1, 2018
A new USC study reports that sudden price spikes for some generic drugs—such as the recently reported increases of a decades-old generic heart medication and an antibiotic—are becoming more common.

Reclassification recommendations for drug in 'magic mushrooms'

September 26, 2018
In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule ...

New study finds concurrent use of prescription drugs and dietary supplements could pose health risks

September 25, 2018
A new University of Hertfordshire study found that using certain over-the-counter herbal medicines and dietary supplements alongside prescription drugs could pose serious health risks, especially amongst older adults.

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

eaglewynd
not rated yet Feb 12, 2018
Anyone aware of recent studies linking oxycodone/oxycotin to hearing loss?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.